SNDX — Syndax Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Syndax Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	298	447	484	578	583
Net Total Accounts Receivable
Net Total Receivables	0.175	0.429	4.06	1.23	13.9
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	299	448	490	581	603
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.482	1.26	1.06	1.5	2.02
Long Term Investments
Other Long Term Assets
Total Assets	301	450	497	613	725
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18.9	20.7	29.1	58.1	104
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	48.4	41.3	29.8	58.7	437
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	252	408	467	554	288
Total Liabilities & Shareholders' Equity	301	450	497	613	725
Total Common Shares Outstanding